RIAS
COGT icon

Rachor Investment Advisory Services’s Cogent Biosciences COGT Stock Holding History

Rachor Investment Advisory Services’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7
Closed -$270 – 257
2026
Q1 		$270 Hold
7
– – ﹤0.01% 421
2025
Q4 		$249 Buy
+7
New +$197 ﹤0.01% 383

Other funds holding COGT

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.97B AUM 30.33% 1-Year Est. Return

Rachor Investment Advisory Services's COGT Position: Q2 2026 in Review

Rachor Investment Advisory Services sold out of Cogent Biosciences (COGT) in Q2 2026, closing a stake of 7 shares — an estimated $270 sold.

Rachor Investment Advisory Services first reported a position in COGT in Q4 2025 and held it in 2 quarters. The position peaked at $270 in Q1 2026. 78 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Rachor Investment Advisory Services reported no remaining Cogent Biosciences position as of Q2 2026 after selling out during the quarter.
  • Rachor Investment Advisory Services sold 7 Cogent Biosciences shares in Q2 2026, an estimated $270.
  • Rachor Investment Advisory Services first reported a position in Cogent Biosciences in Q4 2025 and held it in 2 quarters.
  • Rachor Investment Advisory Services's Cogent Biosciences position peaked at $270 in Q1 2026.
  • 78 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Rachor Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.